How is Sermorelin administered?
This describes how Sermorelin is typically administered in clinical and research references, not a self-administration guide. The usual route is Subcutaneous, on a once daily, typically before bed schedule, generally over 12-24 weeks. Specific dosing is individual and beyond general information, and human evidence for Sermorelin is limited.
Administration at a glance (reference data)
- Route: Subcutaneous
- Schedule: Once daily, typically before bed
- Cycle length: 12-24 weeks
- Half-life: ~10-20 minutes
References
- Sermorelin: a better approach to GH supplementation? — Walker RF, Clin Interv Aging, 2006
- Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiency — Prakash A & Goa KL, BioDrugs, 1999
- Treatment of radiation-induced growth hormone deficiency with growth hormone-releasing hormone — Ogilvy-Stuart AL et al., Clinical Endocrinology (Oxford), 1997
Pepdex is an editorial reference, not medical advice. Peptides vary in legal and approval status by country, many are research compounds without full human safety data. Talk to a qualified clinician before starting anything.
More on Sermorelin
Full Sermorelin breakdownSermorelin what it's used forSermorelin side effectsSermorelin mistakes to avoidSermorelin who should avoid itSermorelin half-lifeSermorelin how long to workSermorelin legal statusSermorelin how it workshgh vs sermorelintesamorelin vs sermorelincjc 1295 vs sermorelinAsk the AI Coach
Last updated 2026-06-15.